These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 9027270)

  • 21. Intra-cardiac echocardiography guided cardioversion to help interventional procedures (ICE-CHIP) study: study design and methods.
    Rao HB; Saksena S; Mitruka R;
    J Interv Card Electrophysiol; 2005 Aug; 13 Suppl 1():31-6. PubMed ID: 16133853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Economic analysis of a transesophageal echocardiography-guided approach to cardioversion of patients with atrial fibrillation: the ACUTE economic data at eight weeks.
    Klein AL; Murray RD; Becker ER; Culler SD; Weintraub WS; Jasper SE; Lieber EA; Apperson-Hansen C; Heerey AM; Grimm RA;
    J Am Coll Cardiol; 2004 Apr; 43(7):1217-24. PubMed ID: 15063433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation: ACUTE trial update.
    Asher CR; Klein AL;
    Card Electrophysiol Rev; 2003 Dec; 7(4):387-91. PubMed ID: 15071261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparing TEE- vs Non-TEE-guided cardioversion of atrial fibrillation: The ENSURE-AF trial.
    Kozieł M; Merino JL; De Caterina R; Huber K; Jin J; Melino M; Goette A; Lip GYH;
    Eur J Clin Invest; 2020 May; 50(5):e13221. PubMed ID: 32150758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bleeding complications in patients with atrial fibrillation undergoing cardioversion randomized to transesophageal echocardiographically guided and conventional anticoagulation therapies.
    Klein AL; Murray RD; Grimm RA; Li J; Apperson-Hansen C; Jasper SE; Goodman-Bizon AS; Lieber EA; Black IW;
    Am J Cardiol; 2003 Jul; 92(2):161-5. PubMed ID: 12860217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of enoxaparin compared with unfractionated heparin for short-term antithrombotic therapy in atrial fibrillation patients undergoing transoesophageal echocardiography-guided cardioversion: assessment of Cardioversion Using Transoesophageal Echocardiography (ACUTE) II randomized multicentre study.
    Klein AL; Jasper SE; Katz WE; Malouf JF; Pape LA; Stoddard MF; Apperson-Hansen C; Lieber EA;
    Eur Heart J; 2006 Dec; 27(23):2858-65. PubMed ID: 17098762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of transesophageal contrast echocardiography for excluding left atrial appendage thrombi in patients with atrial fibrillation before cardioversion.
    von der Recke G; Schmidt H; Illien S; Lüderitz B; Omran H
    J Am Soc Echocardiogr; 2002 Oct; 15(10 Pt 2):1256-61. PubMed ID: 12411914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transesophageal echocardiography-guided cardioversion of atrial fibrillation. Selection of a low-risk group for immediate cardioversion.
    Fonseca N; Caetano F; Santos J; Seixo F; Bernardino L; Silvestre I; Cardoso P; Segurado F; Inês L
    Rev Port Cardiol; 2004 Mar; 23(3):365-75. PubMed ID: 15185562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Transesophageal echocardiography in patients with atrial fibrillation, candidates for cardioversion: usefulness and limitations].
    Antonielli E; Pizzuti A; Gandolfo N; Bosco M; Sclavo M; Magnacca M; Leonardi G; Doronzo B; Baralis G; Di Leo M
    G Ital Cardiol; 1995 May; 25(5):543-52. PubMed ID: 7642059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transesophageal echocardiography for early cardioversion of atrial fibrillation.
    Kamp O; Verhorst PM; Visser CA
    Am J Cardiol; 2000 Aug; 86(4A):46G-50G. PubMed ID: 10997355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Health status outcomes after cardioversion for atrial fibrillation: results from the Assessment of Cardioversion Using Transesophageal Echocardiography (ACUTE) II Trial.
    Elliott DJ; Zhao L; Jasper SE; Lieber EA; Klein AL; Weintraub WS
    Am Heart J; 2008 Aug; 156(2):374.e1-6. PubMed ID: 18657673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Should all patients undergo transesophageal echocardiography before electrical cardioversion of atrial fibrillation?
    Grimm RA; Stewart WJ; Black IW; Thomas JD; Klein AL
    J Am Coll Cardiol; 1994 Feb; 23(2):533-41. PubMed ID: 8294710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous transesophageal cardioversion and echocardiography: feasibility and safety.
    Mischke K; Schimpf T; Winograd R; Knackstedt C; Zarse M; Plisiene J; Hanrath P; Kelm M; Schauerte P
    Heart Rhythm; 2007 Mar; 4(3):304-7. PubMed ID: 17341393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
    Stellbrink C; Nixdorff U; Hofmann T; Lehmacher W; Daniel WG; Hanrath P; Geller C; Mügge A; Sehnert W; Schmidt-Lucke C; Schmidt-Lucke JA;
    Circulation; 2004 Mar; 109(8):997-1003. PubMed ID: 14967716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transoesophageal echocardiography-guided cardioversion of atrial fibrillation or flutter. Selection of a low-risk group for immediate cardioversion.
    Roijer A; Eskilsson J; Olsson B
    Eur Heart J; 2000 May; 21(10):837-47. PubMed ID: 10781356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of embolic events after cardioversion of atrial fibrillation. Current and evolving strategies.
    Kinch JW; Davidoff R
    Arch Intern Med; 1995 Jul; 155(13):1353-60. PubMed ID: 7794083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Limitations of transesophageal echocardiography in the risk assessment of patients before nonanticoagulated cardioversion from atrial fibrillation and flutter: an analysis of pooled trials.
    Moreyra E; Finkelhor RS; Cebul RD
    Am Heart J; 1995 Jan; 129(1):71-5. PubMed ID: 7817928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utility of transesophageal echocardiography in identification of thrombogenic milieu in patients with atrial fibrillation (an ACUTE ancillary study).
    Thambidorai SK; Murray RD; Parakh K; Shah TK; Black IW; Jasper SE; Li J; Apperson-Hansen C; Asher CR; Grimm RA; Klein AL;
    Am J Cardiol; 2005 Oct; 96(7):935-41. PubMed ID: 16188520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Atrial fibrillation and cardioversion: role of transesophageal echocardiography].
    Moreo A; Mauri F
    Ital Heart J Suppl; 2005 Dec; 6(12):780-7. PubMed ID: 16444922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of transesophageal echocardiography guided cardioversion in patients with atrial fibrillation, previous left atrial thrombus and effective anticoagulation.
    Saeed M; Rahman A; Afzal A; Agoston I; Jammula P; Birnbaum Y; Ware DL; Uretsky BF; Schwarz ER; Rosanio S
    Int J Cardiol; 2006 Nov; 113(3):401-5. PubMed ID: 16822564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.